P
Priyanka A. Shah
Researcher at Gujarat University
Publications - 66
Citations - 982
Priyanka A. Shah is an academic researcher from Gujarat University. The author has contributed to research in topics: Triple quadrupole mass spectrometer & Matrix (chemical analysis). The author has an hindex of 11, co-authored 63 publications receiving 603 citations. Previous affiliations of Priyanka A. Shah include St. Xavier's College-Autonomous, Mumbai.
Papers
More filters
Journal ArticleDOI
Natural biodegradable polymers based nano-formulations for drug delivery: A review.
TL;DR: The aim of this review is to present the current status and scope of natural biodegradable polymers as well as some emerging polymers with special characteristics as suitable carriers for drug delivery applications.
Journal ArticleDOI
Guar gum: Versatile natural polymer for drug delivery applications
TL;DR: This review article provides a comprehensive overview of different modifications made on guar gum through derivatization in the quest to make them more versatile for drug delivery applications.
Journal ArticleDOI
LC–tandem mass spectrometry method for the simultaneous determination of metformin and sitagliptin in human plasma after ion-pair solid phase extraction
TL;DR: A reversed-phase liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) method was established for simultaneous determination of two oral hypoglycemic drugs metformin and sitagliptin in human plasma and both the drugs were found to be stable under all mandatory storage conditions.
Journal ArticleDOI
Mixed-mode solid phase extraction combined with LC-MS/MS for determination of empagliflozin and linagliptin in human plasma
TL;DR: In this paper, a liquid chromatography-tandem mass spectrometry method was developed and validated for the concurrent determination of antidiabetic drugs, empagliflozin and linagliptin in human plasma.
Journal ArticleDOI
LC-MS/MS analysis of metformin, saxagliptin and 5-hydroxy saxagliptin in human plasma and its pharmacokinetic study with a fixed-dose formulation in healthy Indian subjects.
TL;DR: The validated method was successfully applied to a bioequivalence study with a fixed-dose formulation consisting of 5 mg SAXA and 500’mg MET in 18 healthy subjects and the reproducibility of the assay was demonstrated by reanalysis of 87 incurred samples.